Literature DB >> 18467524

Luteinizing hormone receptor activation in ovarian granulosa cells promotes protein kinase A-dependent dephosphorylation of microtubule-associated protein 2D.

Maxfield P Flynn1, Evelyn T Maizels, Amelia B Karlsson, Thomas McAvoy, Jung-Hyuck Ahn, Angus C Nairn, Mary Hunzicker-Dunn.   

Abstract

The actions of LH to induce ovulation and luteinization of preovulatory follicles are mediated principally by activation of cAMP-dependent protein kinase (PKA) in granulosa cells. PKA activity is targeted to specific locations in many cells by A kinase-anchoring proteins (AKAPs). We previously showed that FSH induces expression of microtubule-associated protein (MAP) 2D, an 80-kDa AKAP, in rat granulosa cells, and that MAP2D coimmunoprecipitates with PKA-regulatory subunits in these cells. Here we report a rapid and targeted dephosphorylation of MAP2D at Thr256/Thr259 after treatment with human chorionic gonadotropin, an LH receptor agonist. This event is mimicked by treatment with forskolin or a cAMP analog and is blocked by the PKA inhibitor myristoylated-PKI, indicating a role for cAMP and PKA signaling in phosphoregulation of granulosa cell MAP2D. Furthermore, we show that Thr256/Thr259 dephosphorylation is blocked by the protein phosphatase 2A (PP2A) inhibitor, okadaic acid, and demonstrate interactions between MAP2D and PP2A by coimmunoprecipitation and microcystin-agarose pull-down. We also show that MAP2D interacts with glycogen synthase kinase (GSK) 3beta and is phosphorylated at Thr256/Thr259 by this kinase in the basal state. Increased phosphorylation of GSK3beta at Ser9 and the PP2A B56delta subunit at Ser566 is observed after treatment with human chorionic gonadotropin and appears to result in LH receptor-mediated inhibition of GSK3beta and activation of PP2A, respectively. Taken together, these results show that the phosphorylation status of the AKAP MAP2D is acutely regulated by LH receptor-mediated modulation of kinase and phosphatase activities via PKA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467524      PMCID: PMC2453602          DOI: 10.1210/me.2007-0457

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  81 in total

1.  Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics.

Authors:  S Illenberger; G Drewes; B Trinczek; J Biernat; H E Meyer; J B Olmsted; E M Mandelkow; E Mandelkow
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

2.  Recombinant microtubule-associated protein 2c reduces the dynamic instability of individual microtubules.

Authors:  T C Gamblin; K Nachmanoff; S Halpain; R C Williams
Journal:  Biochemistry       Date:  1996-09-24       Impact factor: 3.162

3.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205.

Authors:  M Goedert; R Jakes; E Vanmechelen
Journal:  Neurosci Lett       Date:  1995-04-21       Impact factor: 3.046

Review 4.  Flicking the switches: phosphorylation of serine/threonine protein phosphatases.

Authors:  D L Brautigan
Journal:  Semin Cancer Biol       Date:  1995-08       Impact factor: 15.707

5.  Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin.

Authors:  B Favre; P Turowski; B A Hemmings
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

6.  Gonadotropins induce rapid phosphorylation of the 3',5'-cyclic adenosine monophosphate response element binding protein in ovarian granulosa cells.

Authors:  A Mukherjee; O K Park-Sarge; K E Mayo
Journal:  Endocrinology       Date:  1996-08       Impact factor: 4.736

7.  cAMP counter-regulates insulin-mediated protein phosphatase-2A inactivation in rat skeletal muscle cells.

Authors:  N Begum; L Ragolia
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

8.  Phosphorylation and dephosphorylation in the proline-rich C-terminal domain of microtubule-associated protein 2.

Authors:  C Sánchez; P Tompa; K Szücs; P Friedrich; J Avila
Journal:  Eur J Biochem       Date:  1996-11-01

9.  Genomic structure of human microtubule-associated protein 2 (MAP-2) and characterization of additional MAP-2 isoforms.

Authors:  N Kalcheva; J Albala; K O'Guin; H Rubino; C Garner; B Shafit-Zagardo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau.

Authors:  P Seubert; M Mawal-Dewan; R Barbour; R Jakes; M Goedert; G V Johnson; J M Litersky; D Schenk; I Lieberburg; J Q Trojanowski
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

View more
  21 in total

1.  Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase.

Authors:  Xiaoying Hou; Edward W Arvisais; John S Davis
Journal:  Endocrinology       Date:  2010-03-29       Impact factor: 4.736

Review 2.  Luteinizing hormone: Evidence for direct action in the CNS.

Authors:  Jeffrey A Blair; Sabina Bhatta; Henry McGee; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-07-12       Impact factor: 3.587

3.  Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes.

Authors:  Jeremy R Egbert; Leia C Shuhaibar; Aaron B Edmund; Dusty A Van Helden; Jerid W Robinson; Tracy F Uliasz; Valentina Baena; Andreas Geerts; Frank Wunder; Lincoln R Potter; Laurinda A Jaffe
Journal:  Development       Date:  2014-09       Impact factor: 6.868

4.  The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) Regulates β-Catenin through Its Interactions with Both Protein Kinase A (PKA) and GSK3β.

Authors:  Alessandro Dema; Micha Friedemann Schröter; Ekaterina Perets; Philipp Skroblin; Marie Christine Moutty; Veronika Anita Deàk; Walter Birchmeier; Enno Klussmann
Journal:  J Biol Chem       Date:  2016-08-02       Impact factor: 5.157

5.  Cellular Heterogeneity of the Luteinizing Hormone Receptor and Its Significance for Cyclic GMP Signaling in Mouse Preovulatory Follicles.

Authors:  Valentina Baena; Corie M Owen; Tracy F Uliasz; Katie M Lowther; Siu-Pok Yee; Mark Terasaki; Jeremy R Egbert; Laurinda A Jaffe
Journal:  Endocrinology       Date:  2020-07-01       Impact factor: 4.736

6.  Luteinizing hormone receptor-stimulated progesterone production by preovulatory granulosa cells requires protein kinase A-dependent activation/dephosphorylation of the actin dynamizing protein cofilin.

Authors:  Amelia B Karlsson; Evelyn T Maizels; Maxfield P Flynn; Jonathan C Jones; Eric A Shelden; James R Bamburg; Mary Hunzicker-Dunn
Journal:  Mol Endocrinol       Date:  2010-07-07

Review 7.  Regulation of Mammalian Oocyte Meiosis by Intercellular Communication Within the Ovarian Follicle.

Authors:  Laurinda A Jaffe; Jeremy R Egbert
Journal:  Annu Rev Physiol       Date:  2016-11-14       Impact factor: 19.318

8.  Glycogen synthase kinase 3beta interaction protein functions as an A-kinase anchoring protein.

Authors:  Christian Hundsrucker; Philipp Skroblin; Frank Christian; Hans-Michael Zenn; Viola Popara; Mangesh Joshi; Jenny Eichhorst; Burkhard Wiesner; Friedrich W Herberg; Bernd Reif; Walter Rosenthal; Enno Klussmann
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

Review 9.  A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

10.  Dephosphorylation of MAP2D enhances its binding to vimentin in preovulatory ovarian granulosa cells.

Authors:  Maxfield P Flynn; Sarah E Fiedler; Amelia B Karlsson; Daniel W Carr; Evelyn T Maizels; Mary Hunzicker-Dunn
Journal:  J Cell Sci       Date:  2016-06-22       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.